Data on VIVITROL® to be Presented at Upcoming American Psychiatric Association Annual Meeting

Data on VIVITROL® to be Presented at Upcoming American Psychiatric Association Annual Meeting
WALTHAM, Mass.—-Alkermes, Inc. today announced that new data from several company-sponsored studies of naltrexone for extended-release injectable suspension are scheduled to be presented at the 2010 American Psychiatric Association Annual Meeting in New Orleans, May 22-26, 2010.

Read more on Business Wire via Yahoo! Finance

More Meth Drug Addiction Info: